Novartis invests $39 million in Halle: new job engine for the region!

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

Novartis is investing $39 million in a new radioligand therapy manufacturing facility in Halle, Saxony-Anhalt.

Novartis investiert 39 Millionen US-Dollar in eine neue Produktionsstätte für Radioligandentherapien in Halle, Sachsen-Anhalt.
Novartis is investing $39 million in a new radioligand therapy manufacturing facility in Halle, Saxony-Anhalt.

Novartis invests $39 million in Halle: new job engine for the region!

On November 11, 2025 there will be exciting news from Halle (Saale): The drug manufacturer Novartis announced the construction of a new production facility for radioligand therapies (RLT). This announcement was made on Monday afternoon in Magdeburg and at the same time brings a breath of fresh air to the region.

With an investment of around 39 million US dollars, or around 36 million euros, Novartis would like to break new ground in patient care in Halle. The plant is scheduled to be commissioned by the end of 2027 and will create around 25 highly skilled jobs. Manfred Heinzer, CEO of Novartis Germany, emphasized how crucial innovation is for investments and progress. Saxony-Anhalt's Economics Minister Sven Schulze (CDU) also sees this decision as an important signal for the health sector and Saxony-Anhalt as a location for innovation.

Relevance to the healthcare sector

The new Novartis facility will not only boost the regional economy, but is also considered a central part of the national health strategy. Tino Sorge (CDU), Parliamentary State Secretary in the Federal Ministry of Health, emphasized the importance of this investment for progress in the healthcare system. Halle's mayor Alexander Vogt (independent) sees the project as strengthening the technology location and as an impulse for future investments in Halle.

The state of Saxony-Anhalt will also support the project with funding that will serve both to secure skilled workers and to promote the environment. These multiple levels of support are crucial to ensuring the long-term development of the industry in the region.

Outside the box

This neurological disorder, in which sufferers have difficulty visually identifying recognizable objects, requires special adaptations. Although treatment cannot directly cure this deficit, there is a possibility of improvement depending on the underlying cause. Professional therapies and rehabilitation can help develop techniques to use other senses to identify objects and achieve adaptive behavior patterns.

In summary, Halle is now facing a promising development, while at the same time the discussion about innovations in medicine and our daily challenges continues. Investments in healthcare locations are proving valuable for the entire region and beyond.